| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Murray Mark Christopher | SVP - Acetyls | 222 W. LAS COLINAS BLVD, STE 900N, IRVING | /s/ Blake Feikema, Attorney-in-Fact for Mark Christopher Murray | 18 Feb 2026 | 0001800013 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CE | Common Stock | Award | $0 | +1,205 | +7.1% | $0.000000 | 18,205 | 15 Feb 2026 | Direct | F1 |
| transaction | CE | Common Stock | Tax liability | $21,106 | -357 | -2% | $59.12 | 17,848 | 15 Feb 2026 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Represents performance-based restricted stock units ("PRSUs") granted to the reporting person on February 8, 2023 under the Company's 2018 Global Incentive Plan, as amended, which have vested and been settled. |
| F2 | Shares withheld for the payment of taxes on the vesting and settlement of PRSUs. |